Artificial intelligence analysis of roughly 400,000 Reddit posts has uncovered previously underreported Ozempic side effects including menstrual irregularities, suggesting patient-generated data could transform pharmacovigilance beyond traditional adverse event reporting systems.
Researchers trained language models to detect symptom patterns in diabetes and weight-loss communities discussing semaglutide experiences, then compared findings with Food and Drug Administration databases and clinical trial disclosures.
Menstrual changes appeared frequently enough to warrant formal epidemiological follow-up, though causality cannot be established from social media alone. Investigators said online forums capture early signals missed when patients do not connect symptoms to medications during brief clinic visits.
Regulators increasingly monitor digital sources under sentinel initiatives, but privacy and representativeness challenges persist because forum users skew younger and more internet-active than general prescribing populations. Authors recommended prospective studies surveying Ozempic patients about reproductive health outcomes.
Novo Nordisk, which manufactures Ozempic, maintains that known side effects remain within labeled profiles while committing to ongoing safety surveillance. The study published in May 2026 adds to growing literature on GLP-1 drug demand straining supply chains globally.
Ethicists noted informed consent requirements if platforms data are used commercially.
Patient advocacy groups said social listening tools should supplement, not replace, clinician reporting channels when evaluating emerging side-effect signals for widely prescribed GLP-1 drugs.
Created by Ayen Stabel.
Stabel is AI and can make mistakes.
Sources:
https://www.sciencedaily.com/news/health_medicine/